510(k) Report

510(k) · Cleared

Cleared

Abt Glucose Control Solution, Model: 2120089

K090943510(k) TraditionalCleared May 27, 200954-day reviewClass I21 CFR 862.1660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

American Biological Technologies, Inc. · JJX Single (Specified) Analyte Controls (Assayed And Unassayed)

Cleared on May 27, 2009 as substantially equivalent to K052762 (Agamatrix, Inc., 2006) and 1 other predicate after a 54-day review. Its family tree reaches back 7 generations to 1995.

Decided
May 27, 2009
Review
54 days
Class
Class I
Product code
JJX
Recalls
None
Predicates
2

Its longest line of descent runs back 7 generations to K945887 (1995). 14 ancestors in all, the oldest K850368 (1985). No later device cites it as a predicate yet.

  1. Root · 7 generations backK945887 Precision Q I D Blood Glucose Test StripsMedisense, Inc. · 1995
  2. 6 generations backK962295 Precision Qid Blood Glucose Test StripMedisense, Inc. · 1996
  3. 5 generations backK963676 Precision G Blood Glucose Testing SystemMedisense, Inc. · 1997
  4. 4 generations backK971812 Precision Qid Blood Glucose Test Strip, Precision G Blood Glucose…Medisense, Inc. · 1997
  5. 3 generations backK983504 Precision Xtra Advanced Diabetes Management System, Precision Blood…Medisense, Inc. · 1999 · Recalled
  6. 2 generations backK052980 Liberty Glucose Control, Model 2120031Liberty Healthcare Group, Inc. · 2005
  7. 1 generation backK063855 Liberty Normal Glucose Control Solution, Model 2120045/ High Glucose…Liberty Healthcare Group, Inc. · 2007
  8. This deviceK090943 Abt Glucose Control Solution, Model: 2120089American Biological Technologies, Inc. · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K945887Precision Q I D Blood Glucose Test StripsMedisense, Inc.1995—
−6K962295Precision Qid Blood Glucose Test StripMedisense, Inc.1996—
−5K963676Precision G Blood Glucose Testing SystemMedisense, Inc.1997—
−4K971812Precision Qid Blood Glucose Test Strip, Precision G Blood Glucose Test StripMedisense, Inc.1997—
−3K983504Precision Xtra Advanced Diabetes Management System, Precision Blood Glucose…Medisense, Inc.19991
−2K052980Liberty Glucose Control, Model 2120031Liberty Healthcare Group, Inc.2005—
−1K063855Liberty Normal Glucose Control Solution, Model 2120045/ High Glucose Control…Liberty Healthcare Group, Inc.2007—
0 (this device)K090943Abt Glucose Control Solution, Model: 2120089American Biological Technologies, Inc.2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198510
199010
199110
199520
199610
200610
FIG. 1 — Lineage of K090943, 1995–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JJX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K052762Liberty Blood Glucose Monitoring System, Model 8000-0067
Summary page 1
…Solution Manufacturer: AgaMatrix, Inc. 510(k) No.: K052762 Name: Liberty Normal Control Solution Manufactu…
Agamatrix, Inc.2006—
*K063855Liberty Normal Glucose Control Solution, Model 2120045/ High Glucose Control Solution…
Summary page 1
…ty Normal Control Solution Manufacturer: Liberty Healthcare Group, Inc. 510(k) No.: K063855 Device Description: The AbT Glucose Control Solution consists of a viscosity-adjusted,…
Liberty Healthcare Group, Inc.2007—

Also cleared against K052762: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 3 companies; a new generation was cleared every 1.3 years on median.
  • 1 of the 14 ancestors has a recall of any class.
  • 3 other devices also cite its predicate K052762.

How does its category compare?

All JJX devices

JJX Single (Specified) Analyte Controls (Assayed And Unassayed): FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · JJX

2in 2017

2007: 62008: 82009: 172010: 242011: 192012: 152013: 192014: 222015: 112016: 62017: 2
2007high 24 (2010) · low 0 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JJX

31in 2016

2007: 53 days median2008: 52 days median2009: 80 days median2010: 80 days median2011: 62 days median2012: 40 days median2013: 37 days median2014: 30 days median2015: 65 days median2016: 31 days median
2007high 80 (2009) · low 30 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JJX

1in 2021

2007: 32008: 32010: 32011: 22014: 12015: 12016: 22018: 22021: 1
2007high 3 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JJX

22in 2025

2007: 22009: 12010: 62011: 622012: 322013: 512014: 482015: 672016: 372017: 192018: 352019: 822020: 772021: 432022: 242023: 222024: 302025: 22
2007high 82 (2019) · low 0 (2008)2025

MAUDE reports naming product code JJX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200765332
200885230
2009178001
2010248036
20111962262
20121540032
20131937051
20142230148
20151165167
2016631237
20172—019
20180—235
20190—082
20200—077
20210—143
20220—024
20230—022
20240—030
20250—022
20260—0—

What is it indicated for?

For in vitro diagnostic use (i.e. for external use only) by healthcare professionals

and in the home by people with diabetes mellitus to assess the performance of

the Agamatrix WaveSense Presto Blood Glucose Monitor.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K090943: Abt Glucose Control Solution, Model: 2120089.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K090943

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026